rethinkTHC Search
Menu
Study breakdown

Can Cannabinoids Help Treat ADHD? A Review of the Emerging Evidence

Narrative ReviewPreliminary evidence
The takeaway

A review of the literature finds that people with ADHD are at higher risk for cannabis dependence and may self-medicate with it, while early evidence suggests CBD may have therapeutic potential through dopamine and norepinephrine modulation.

People with ADHD who use or consider using cannabis, and clinicians managing ADHD patients.

People with ADHD are at higher risk for cannabis dependence

What the researchers found

Individuals with ADHD have elevated risk for substance use and cannabis dependence. Some may use cannabis to manage anxiety or medication side effects. Both in vivo and clinical investigations suggest cannabinoids, particularly CBD, may have therapeutic potential in ADHD, possibly through modulation of dopaminergic and noradrenergic systems.

Why it matters

ADHD affects millions of people, and existing medications have significant side effects and limitations. If cannabinoids (particularly CBD) prove effective, they could offer a new treatment option for a population that already uses cannabis at elevated rates.

The numbers in context

Review covers epidemiological data on ADHD-cannabis co-occurrence, self-medication patterns, and multiple proposed pharmacological mechanisms including dopamine and norepinephrine modulation.

How the study worked

Comprehensive narrative review of literature on cannabinoid effects in ADHD, examining epidemiological associations, self-medication patterns, preclinical evidence, clinical studies, and proposed pharmacological mechanisms.

What this study cannot tell us

Narrative review with limited clinical evidence. Most mechanistic evidence is from animal studies. No large-scale RCTs of cannabinoids for ADHD exist. The review cannot determine whether cannabis use in ADHD is beneficial or harmful.

How to read the evidence

Narrative review compiling limited evidence. No large clinical trials exist for cannabinoids in ADHD.

When this study was published

Published in 2025.

The bigger picture

The intersection of ADHD and cannabis use is a growing clinical reality. Understanding whether cannabis use in this population is self-medication versus additional risk is essential for both ADHD treatment and cannabis policy.

Questions still open

  • Could CBD specifically treat ADHD symptoms without the risks of THC? Would controlled clinical trials show benefit, or would the risks outweigh any therapeutic effect?

Common questions

Should people with ADHD use cannabis?
The review highlights both risks (higher dependence vulnerability) and potential benefits (symptom management). There is not enough clinical evidence to recommend cannabis for ADHD, and the higher dependence risk in this population is a significant concern.
Why might CBD help ADHD?
CBD may modulate dopamine and norepinephrine systems that are dysregulated in ADHD. However, this is based primarily on preclinical evidence and has not been confirmed in large human trials.

Read the original research

Cannabinoids and ADHD: a New Frontier in Neuropharmacology?

Journal of molecular neuroscience : MN, 75(4), 146

Citation

Mavaddat, Helia; Fouladi, Abtin; Kashani, Ayeh Sabbagh; Khayatan, Illia; Andarzbaksh, Kamyab; Razavi, Seyed Mehrad; Rezazadeh, Amir. (2025). Cannabinoids and ADHD: a New Frontier in Neuropharmacology?. Journal of molecular neuroscience : MN, 75(4), 146. https://doi.org/10.1007/s12031-025-02435-3

Explore the wider topic